Dynamics of plasma membrane microdomains and cross-talk to the insulin signalling cascade

被引:30
|
作者
Müller, G [1 ]
机构
[1] Aventsi Pharma Germany, DG Metab Dis, D-65926 Frankfurt, Germany
来源
FEBS LETTERS | 2002年 / 531卷 / 01期
关键词
glycosylphosphatidylinositol-anchored proteins; lipid rafts; caveolae; lipid modification; non-receptor tyrosine kinases;
D O I
10.1016/S0014-5793(02)03402-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The critical role of the heterogeneous nature of cellular plasma membranes in transmembrane signal transduction has become increasingly appreciated during the past decade. Areas of relatively disordered, loosely packed phospholipids are disrupted by hydrophobic detergent/carbonate-insoluble glycolipid-enriched raft microdomains (DIGs) of highly ordered (glyco)sphingolipids and cholesterol. DIGs exhibit low buoyant density and are often enriched in glycosylphosphatidylinositol-anchored plasma membrane proteins (GPI proteins), dually acylated signalling proteins, such as non-receptor tyrosine kinases (NRTKs), and caveolin. At least two types of DIGs, hcDIGs and lcDIGs, can be discriminated on basis of higher and lower content, respectively, of these typical DIGs components. In quiescent differentiated cells, GPI proteins and NRTKs are mainly associated with hcDIGs, however, in adipose cells certain insulin-mimetic stimuli trigger redistribution of subsets of GPI proteins and NRTKs from hcDIGs to lcDIGs. Presumably, these stimuli induce displacement of GPI proteins from a GPI receptor located at hcDIGs whereas simultaneously NRTKs dissociate from a complex with caveolin located at hcDIGs, too. NRTKs are thereby activated and, in turn, modulate intracellular signalling pathways, such as stimulation of metabolic insulin signalling in insulin-sensitive cells. The apparent dynamics of DIGs may provide a target mechanism for regulating the activity of lipid-modified signalling proteins by small drug molecules, as exemplified by the sulfonylurea, glimepiride, which lowers blood glucose in an insulin-independent fashion, in part. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 50 条
  • [1] Signalling via caveolin:: involvement in the cross-talk between phosphoinositolglycans and insulin
    Müller, G
    Frick, W
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 56 (11-12) : 945 - 970
  • [2] Cross-talk between insulin signalling and LPS responses in mouse macrophages
    Pal, Soumojit
    Nath, Poulomi
    Das, Debabrata
    Hajra, Sudip
    Maitra, Sudipta
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2018, 476 : 57 - 69
  • [3] Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin
    G. Müller
    W. Frick
    Cellular and Molecular Life Sciences CMLS, 1999, 56 : 945 - 970
  • [4] GA signalling and cross-talk with other signalling pathways
    Lor, Vai S.
    Olszewski, Neil E.
    PLANT HORMONE SIGNALLING, 2015, 58 : 49 - 60
  • [5] Central signalling cross-talk between insulin and leptin in glucose and energy homeostasis
    Boucsein, Alisa
    Kamstra, Kaj
    Tups, Alexander
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 (04)
  • [6] Modular modelling of signalling pathways and their cross-talk
    Donaldson, Robin
    Calder, Muffy
    THEORETICAL COMPUTER SCIENCE, 2012, 456 : 30 - 50
  • [7] Triggering TGFO and notch signalling cross-talk
    Soares, R
    Alçada, MNMP
    Azevedo, I
    BIOESSAYS, 2005, 27 (07) : 763 - 763
  • [8] Insulin signaling in microdomains of the plasma membrane
    Saltiel, AR
    Pessin, JE
    TRAFFIC, 2003, 4 (11) : 711 - 716
  • [9] Mitigating Biological Signalling Cross-talk with Feedback Control
    Steel, Harrison
    Sootla, Aivar
    Delalez, Nicolas
    Papachristodoulou, Antonis
    2019 18TH EUROPEAN CONTROL CONFERENCE (ECC), 2019, : 2638 - 2643
  • [10] Cross-talk between xenobiotics signalling and oxidative stress
    Barouki, Robert
    Garlatti, Michèle
    Marchand, Alexandre
    Gouedard, Cedric
    Morel, Yannick
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 36 - 36